Drug factory · FDA FEI 3015838038

Harman Finochem Limited

A-100/1 Finished Dosage Form (FDF), M.I.D.C. Industrial Area, Shendra, Chhatrapati Sambhajinagar, India

India: 1

No problems found at FDA's last inspection, Feb 23, 2024.

No Action Indicated: inspectors found no objectionable conditions.

1 drug inspection on record since 2024: 1 with no problems, 0 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
AllopurinolMakes it Harman Finochem Limited, Leading Pharma, LLC 82638-112, 82638-113, 69315-291 +2
BisoprololMakes it Caraco Pharmaceutical Laboratories, Ltd., Harman Finochem Limited 70095-019, 70095-020, 82638-107 +1
MetforminMakes it Ascend Laboratories, LLC, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 67877-930, 67877-931, 67877-932 +3
Sacubitrilat and ValsartanMakes it Amneal Pharmaceuticals 69238-2731, 69238-2732, 69238-2733
TheophyllineMakes it Harman Finochem Limited 82638-105, 82638-106

FDA inspection history

EndedResultProgramProblems noted
Feb 23, 2024No problems foundDrug Quality Assurance—

Registered with FDA for: manufacture.